awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33375915-3B19A70C-3C7F-49BF-9DDF-FCF207A92A0D
Q33375915-3B19A70C-3C7F-49BF-9DDF-FCF207A92A0D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33375915-3B19A70C-3C7F-49BF-9DDF-FCF207A92A0D
Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia.
P2860
Q33375915-3B19A70C-3C7F-49BF-9DDF-FCF207A92A0D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33375915-3B19A70C-3C7F-49BF-9DDF-FCF207A92A0D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9df8dcb5b47791a786177a3b6653645524882f70
P2860
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.